Entrepreneur Briefs

Maryland Governor William Schaefer hopes to encourage more high-tech entrepreneurship in his state with a $15 million seed-capital fund he proposed to his state's General Assembly last month. The plan calls for a pool of money - mostly from public pension funds - that would be invested in venture capital firms; these firms would match the state investment and provide capital for high-tech startups. J. Randall Evans, secretary of the Maryland Department of Economic Development, says there could

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Maryland Governor William Schaefer hopes to encourage more high-tech entrepreneurship in his state with a $15 million seed-capital fund he proposed to his state's General Assembly last month. The plan calls for a pool of money - mostly from public pension funds - that would be invested in venture capital firms; these firms would match the state investment and provide capital for high-tech startups. J. Randall Evans, secretary of the Maryland Department of Economic Development, says there could be many Maryland scientists ready to jump into the marketplace: "We've got an awful lot of smart people doing public-funded basic research here, and now it's time to make it possible to commercialize it." Schaefer's plan encourages the state's counties to invest one half of 1% of their pension funds in the venture pool. Unlikely to participate in the pool, however, is the $8.5 billion State Retirement and Pension Systems Fund. Howard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies